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Abstract
Background:  The ubiquitin-proteasome system is the predominant pathway for myofibrillar
proteolysis but a previous study in C2C12 myotubes only observed alterations in lysosome-
dependent proteolysis in response to complete starvation of amino acids or leucine from the
media. Here, we determined the interaction between insulin and amino acids in the regulation of
myotube proteolysis
Results: Incubation of C2C12 myotubes with 0.2 × physiological amino acids concentration (0.2
× PC AA), relative to 1.0 × PC AA, significantly increased total proteolysis and the expression of
14-kDa E2 ubiquitin conjugating enzyme (p < 0.05). The proteasome inhibitor MG132 blocked the
rise in proteolysis observed in the 0.2 × PC AA media. Addition of insulin to the medium inhibited
proteolysis at both 0.2 and 1.0× PC AA and the expression of 14-kDa E2 proteins and C2 sub unit
of 20 S proteasome (p < 0.05). Incubation of myotubes with increasing concentrations of leucine
in the 0.2 × PC AA media inhibited proteolysis but only in the presence of insulin. Incubation of
rapamycin (inhibitor of mTOR) inhibited amino acid or insulin-dependent p70 S6 kinase
phosphorylation, blocked (P < 0.05) the inhibitory effects of 1.0 × PC AA on protein degradation,
but did not alter the inhibitory effects of insulin or leucine
Conclusion: In a C2C12 myotube model of myofibrillar protein turnover, amino acid limitation
increases proteolysis in a ubiquitin-proteasome-dependent manner. Increasing amino acids or
leucine alone, act additively with insulin to down regulate proteolysis and expression of
components of ubiquitin-proteasome pathway. The effects of amino acids on proteolysis but not
insulin and leucine, are blocked by inhibition of the mTOR signalling pathway.
Background
Starvation induces muscle wasting by decreasing the rate
of muscle protein synthesis and increasing protein degra-
dation. A decrease in plasma concentrations of amino
acids, and in particular branched-chain amino acids, is
thought to synergise with lower levels of insulin to signal
the starvation-induced decrease in protein synthesis [1]
but the mechanisms responsible for the up regulation of
muscle proteolysis are less well characterised. The major
proteolytic systems that are activated in atrophying skele-
tal muscle are lysosomal, calcium dependent and ATP
dependent ubiquitin-proteasome pathway [2]. Of these,
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the latter is considered the predominant biological mech-
anism controlling protein degradation in myofibrillar
proteins in skeletal muscle [3]. This proteolytic pathway
comprises of a cascade of ATP dependent enzymatic reac-
tions in which ubiquitin protein is activated by ubiquitin
activating enzyme, E1, which then transfers ubiquitin to
ubiquitin conjugating enzyme, E2. This assembly then
binds either directly to protein substrate or involves
another ligating enzyme, E3. The cycle continues to pro-
duce a polyubiquitinated protein substrate which then
enters the 26 S proteasome complex for rapid degrada-
tion. The 20 S proteasome, catalytic core of 26 S proteas-
ome, comprises subunits having peptidase activity, which
digest proteins [4]. Increased expression of 14-kDa E2 and
E3 ubiquitin ligases, atrogin-1/MAFbx and MuRF1 has
been observed in atrophying muscle [5,6].
Low level of plasma insulin triggers protein degradation
in muscle through activation of the ubiquitin-proteasome
pathway [7,8] while higher levels down regulate the
expression of 14-kDa E2 conjugating enzyme proteins in
vitro [9]. In vivo, a 6-hour hyperinsulinaemic, hyper-ami-
noacidaemic and euglycaemic clamp significantly reduced
the mRNA expression for ubiquitin in fast twitch and
mixed skeletal muscle [10]. Constant infusions of glucose
and a mixture of essential amino acids in calves signifi-
cantly attenuated mRNA expression for C2 sub unit of 20
S proteasome [11]. Observations in hepatoma cells have
revealed that insulin regulates its anticatabolic activity by
decreasing ubiquitin mediated proteasomal activity [12].
Despite the evidence that the ubiquitin-proteasome path-
way may be responsible for the increased rates of muscle
proteolysis during fasting, in vitro studies in C2C12 myo-
tubes and hepatocytes have suggested that lysosome-
dependent autophagic pathway is responsible for proteo-
lytic responses to complete starvation of amino acids or
from complete media [13,14].
Signalling cascades that regulate intracellular protein
phosphorylation during nutrient deficiency and hormo-
nal imbalance are not well characterised. Studies in vari-
ous cell types have demonstrated that the mammalian
target of rapamycin (mTOR) signalling pathway, inte-
grates the effects of insulin and amino acids on muscle
protein synthesis through phosphorylation of two key
regulators of translation, 70 kDa ribosomal protein S6
kinase (p 70 S6) and eukaryotic initiation factor 4 E bind-
ing protein-1 (4EBP-1) [15,16]. mTOR has also been
identified as an important protein kinase in the starva-
tion-signalling pathway of autophagy [17] and activation
of S6 kinase is associated with autophagy in rat hepato-
cytes [18] C2C12 myotubes [13].
In this paper we test the hypothesis that the antiproteo-
lytic actions of insulin and amino acids in C2C12 myo-
tubes are mediated by the ubiquitin-dependent
proteasome pathway. Our data demonstrate that low lev-
els of amino acids increase ubiquitin-proteasome-
dependent proteolysis in myotubes and that amino acids
act additively with insulin.
Results
It is an inherent characteristic of C2C12 myoblasts that
they fuse into multinucleated myotubes when the level of
serum in the incubation medium is reduced. The expres-
sion of many muscle specific genes such as creatine
kinase, desmin and myosin heavy chain is increased dur-
ing myogenic differentiation [19,20]. Differentiation of
myotubes was confirmed by approximately 30-fold
increase in CPK activity relative to unfused myoblasts
(Figure 1.) and by visualisation under phase contrast
microscopy of elongated, multinucleated cells. CPK activ-
ity remained high under all incubation conditions (results
not shown).
Effect of insulin on total protein degradation
Initially we aimed to determine the concentration of insu-
lin that can significantly inhibit proteolysis during 8
hours of incubation. Insulin inhibited the release of TCA
soluble radioactivity from C2C12 myotubes pre-labelled
with L[ring -3, 5-3H]-tyrosine at all of the concentrations
employed with the half-maximal effect on proteolysis of
approximately 10 -8 M (P < 0.01) (Figure 2).
Amino acids and insulin act additively to regulate total 
proteolysis
Physiological (1.0 × PC AA) and sub-physiological con-
centration of amino acids (0.2 × PC AA) were used to
determine the interaction between amino acids and insu-
lin in the regulation of skeletal muscle protein degrada-
tion. Protein degradation was increased by 9–12% when
CPK and protein measurements Figure 1
CPK and protein measurements. CPK (open diamonds) 
and protein (filled diamonds) concentration in C2C12 myo-
tubes during 5 days incubation in differentiating mediaBMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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differentiated myotubes were incubated with the amino
acid limiting 0.2 × PC AA media compared with 1.0 × PC
AA, in both the absence and presence of insulin (P <
0.001; Figure 3). Insulin addition (10 -8 M) to the media
decreased protein degradation (18 to 21%) at both con-
centrations of amino acids (p < 0.001; Figure 3). The
inhibitory effects of amino acids and insulin on protein
degradation in differentiated C2C12 cells were additive.
Proteasome inhibitor MG132 attenuates amino acid 
mediated total proteolysis
Next we employed the proteasome inhibitor MG132 (50
μM) to determine the role of the 26S proteasome pathway
in responses to varying amino acid concentration. MG132
inhibited proteolysis by about 75% in incubations with
both physiological and sub-physiological concentrations
of amino acids, but importantly, the inhibitor abolished
the difference in proteolysis between the two amino acid
levels (P < 0.0001; Fig 4). This result demonstrated that
media amino acid depletion increased ubiquitin-proteas-
ome-dependent-proteolysis in C2C12 myotubes.
Amino acids and insulin down regulate expression of 
components of ubiquitin-proteasome pathway
Having observed significant additive changes in total pro-
tein degradation in response to increasing amino acid and
insulin media concentrations, we next sought to discover
whether changes in the expression of components of the
ubiquitin-proteasome pathway were also sensitive to
these treatments. Compared to 1 × PC AA, the 0.2 × PC AA
medium elicited a significant increase in mRNA expres-
sion of the 14-kDa E2 conjugating enzyme of the ubiqui-
tin-proteasome pathway in C2C12 myotubes (P < 0.05;
Figure 5). When insulin was added to the medium there
was a decrease in the expression of the gene encoding 14-
kDa E2 in the presence of both 1.0 × and 0.2 × PC AA (P
< 0.001). Insulin and amino acids were observed to have
additive inhibitory effects on 14-kDa E2 gene expressions.
Next we sought to determine if the C2 and C8 subunits of
the 20 S proteolytic core of the proteasome were also
responding to the availability of amino acids and insulin.
The expression of the gene encoding C2 was reduced by
21% when C2C12 myotubes were treated with 1.0 × PC
AA, compared to 0.2 × PC AA (P < 0.05). Insulin addition
to media containing either the low or physiological
amino acid concentrations further decreased C2 mRNA
abundance in the myotubes, compared to that observed
in the absence of insulin (P < 0.05). Incubation with the
1.0 × PC AA compared with 0.2 × PC AA elicited an inhib-
itory effect on the expression of C8 in the differentiated
Amino acids and insulin act additively to regulate total prote- olysis in C2C12 myotubes Figure 3
Amino acids and insulin act additively to regulate 
total proteolysis in C2C12 myotubes. Experimental 
procedures are the same as described under Figure 2. Values 
are means ± SEM for 5 different experiments performed in at 
least triplicates. * Indicates differences in protein degradation 
between 0.2 × PC AA (filled bars) & 1.0 × PC AA (open bars) 
treatments. ψ Represents differences between insulin versus 
control (without insulin) groups.
Effect of insulin on protein degradation Figure 2
Effect of insulin on protein degradation. Long-lived pro-
teins in C2C12 myotubes were labelled with 1 μCi L[ring -3, 
5-3H]-tyrosine/ml fusion medium for 48 hours. Myotubes 
were rinsed twice with 1 × HBSS and incubated in 1 × PC 
AA media for 2 hours. Myotubes were rinsed and incubated 
with 10-9, 10-8 and 10-5 M insulin for 8 hours. Samples were 
collected and percent protein degradation was calculated as 
described in material and methods. Values are means ± SEM 
from 5 different experiments performed in at least triplicates. 
* Represents significant difference compared to control (zero 
insulin).BMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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C2 C12 incubations but this was not statistically signifi-
cant.
Leucine increases the inhibitory effect of insulin on protein 
degradation
We next assessed the specific effect of leucine on myotube
protein degradation by supplementing the amino acid
limiting 0.2 × PC AA media with three levels of leucine
ranging from sub-physiological to supra-physiological
(30 μM, 150 μM (physiological concentration) and 750
μM). In the absence of insulin, increasing the concentra-
tion of leucine in the media tended to inhibit myotube
protein degradation but this effect was not significant (P >
0.05). In the presence of insulin, proteolysis was progres-
sively inhibited by the addition of increasing leucine con-
centration with both 150 and 750 μM leucine, being
significantly lower compared to 30 μM leucine (P < 0.001;
Figure 6). These results differed from the inhibitory
response observed in the absence of insulin when the con-
centration of the physiological mixture of amino acids
was increased (Figure 3) and suggest that the effects of
amino acids supply are not simply due to variations in
leucine concentration. The results also indicate that the
inhibitory effect of insulin on myotube protein degrada-
tion is dependent on the presence of a physiological con-
centration of leucine in the media.
Leucine can modulate the expression of components of 
ubiquitin-proteasome pathway
There was a dose dependent decrease in myotube 14-kDa
E2 expression in response to increasing leucine concentra-
tions, both in the presence or absence of insulin and these
effects of leucine and insulin were additive (P < 0.05; Fig-
ure 7). Compared to 30 μM, 750 μM leucine caused a sig-
nificant reduction in myotube expression of C2, both in
the presence and absence of insulin (P < 0.05). No signif-
icant effects of leucine on C8 expression were observed.
Amino acids but not leucine, regulate protein degradation 
and 14-kDa E2 expression through the mTOR signalling 
pathway
The studies reported to date have suggested that both
amino acids and insulin act on protein synthesis through
the mTOR signalling pathway [15]. We therefore tested
the hypothesis that the effects of amino acids and insulin,
on protein degradation in C2C12 myotubes are also
mediated through the mTOR pathway using rapamycin, a
well defined inhibitor of mTOR. In order to validate if
rapamycin was inhibiting phosphorylation of p 70 S6
kinase, western blotting followed by immunodetection
was performed. Rapamycin completely abolished p70 S6
kinase phosphorylation at Thr 389 site (index of total S6
activity in vivo [21]. Uniform bands across the treatments
after reprobing the blot with total p70 S6 kinase antibody
confirmed that the absence of phosphorylated p70 S6
kinase was not merely because of lack of S6 activity in the
samples (Figure 8).
Myotubes were challenged with rapamycin followed by
stimulation with insulin. Rapamycin treatment of cells
did not alter proteolysis during incubations with 0.2 × PC
AA, in the presence and absence of insulin (Figure 9A).
Addition of rapamycin, however, blocked the inhibitory
effect on protein degradation of increasing media amino
acid concentrations from 0.2 × PC AA to 1.0 × PC AA, with
and without insulin (P < 0.001; Figure 9a). Rapamycin
did not block the inhibitory action of insulin, on myotube
protein degradation. In contrast to the effects of low con-
centrations of a physiological mixture of amino acids, the
stimulatory effect of decreasing the media leucine concen-
tration from 750 μM to 30 μM, on myotube protein deg-
radation was not blocked in the presence of rapamycin (P
> 0.05; Figure 9b). As in the previous experiment, rapamy-
cin also failed to alter the inhibitory effect of insulin on
protein degradation.
Rapamycin increased the expression of the ubiquitin con-
jugating enzyme 14-kDa E2 in both the presence and
MG132 blocks amino acid mediated total proteolysis Figure 4
MG132 blocks amino acid mediated total proteolysis. 
Experimental procedures are the same as described under 
Figure 2. Values are means ± SEM for 2 different experiments 
performed in at least triplicates. * Indicates differences in 
protein degradation between 0.2 × PC AA (filled bars) & 1.0 
× PC AA (open bars) treatments. ψ Represents differences 
between MG132 (50 uM) versus control (without MG132) 
groups.BMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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absence of insulin during incubations with 1.0 × PC AA,
although these changes did not attain statistical signifi-
cance (Figure 10).
Taken together these studies with rapamycin demonstrate
that varying the concentration of an amino acid mixture
influences proteolysis and expression of 14-kDa E2, in
C2C12 myotubes, via the mTOR pathway whereas leucine
and insulin act through other pathway(s).
Discussion
The anabolic effect of insulin on muscle protein synthesis
is acutely sensitive to amino acids [1]. Studies on muscle
protein degradation have suggested that amino acids also
influence insulin action but few studies have investigated
the specific cellular pathway involved [22]. The ATP-
dependent ubiquitin-proteasome pathway is the most
likely target for control by insulin and amino acids since
proteasome-dependent-proteolytic activity and expres-
sion of components of this pathway are stimulated by
starvation and inhibited by refeeding and insulin [23].
However, a previous study of protein degradation in
C2C12 myotubes could only find evidence of alterations
in lysosome-dependent proteolysis in response to com-
plete starvation of amino acids or leucine from the media
[13]. We therefore carried out a study to examine the effect
Effect of amino acids and insulin on components of ubiquitin-proteasome pathway Figure 5
Effect of amino acids and insulin on components of ubiquitin-proteasome pathway. Experimental procedure is the 
same as described under Figure 2 except that instead of L[ring -3, 5-3H]-tyrosine cold tyrosine was used to simulate similar 
conditions. Values are means ± SEM for 3–4 experiments performed in triplicates. * Indicates differences in protein degrada-
tion between 0.2 × PC AA (filled bars) & 1.0 × PC AA (open bars) treatments while ψ represents differences between insulin 
versus control (without insulin) groups. Autoradiographic signals were normalised for GAPDH expression. In case of 14-kDa 
E2, autoradiographic signals for 1.2 kb transcript were normalised. Mean normalised levels of gene expression are represented 
as arbitrary units.BMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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of more physiological alterations in amino acid concen-
tration on the effect of insulin on the ubiquitin-proteas-
ome pathway in C2C12 myotubes.
This study is the first to report that the amino acids alone,
or additively with insulin, decrease muscle protein degra-
dation by acting on the ubiquitin dependent proteasome
pathway. We also report that varying the concentration of
leucine whilst maintaining all other amino acids at a low
level, does not mimic the effect of varying all amino acid
concentrations suggesting that the response to amino
acids is more than a response to alterations in leucine as
has been previously suggested [13].
Increasing the media amino acid concentration from 0.2
× physiological levels to 1.0 × PC AA decreased myotube
proteolysis as assayed by the release of protein-bound
labelled tyrosine into the medium, but these effects were
abolished by addition of the proteasome inhibitor
MG132. Furthermore, the expression of both the 14-kDa
E2 and C2 sub unit of 20 S proteasome was significantly
increased during incubations with the sub-physiological
amino acid incubation medium. The effect of amino acids
was additive with insulin: maximal stimulation of protein
degradation and expression of 14-kDa E2 and C2 were
observed in the absence of insulin and at 0.2 × amino
acids. Addition of insulin in the presence of amino acids
strongly inhibited proteolysis and expression of 14-kDa
E2 and C2. Depletion or supplementation of media leu-
cine concentration influenced proteolysis but only in the
presence of insulin. These results therefore strongly argue
that insulin and amino acids interact to suppress myotube
proteolysis by acting on the ubiquitin-proteasome path-
way. The tyrosine release assay measures total myotube
protein degradation and is therefore more representative
of muscle protein degradation and is also able to deter-
mine small differences in turnover that are not possible
with the measurement of specific proteins or their rate of
ubiquitlylation.
A previous study in C2C12 cells [13] was unable to find
any effects of amino acid or leucine starvation in the
media on proteasome-dependent proteolysis or expres-
sion of components of this pathway. Our current study
differed from the previous study in two ways: firstly, we
examined the effect of physiological changes in amino
acid concentrations by decreasing to 0.2 × physiological
levels or in the case of leucine, altering the concentrations
whilst maintaining the others at 0.2 × physiological levels.
Secondly, the effects of amino acids were examined alone
or in combination with insulin. Others have reported the
involvement of both lysosomal and ubiquitin-proteas-
ome pathways during incubation of rat skeletal muscle in
vitro in the presence of 10 mM leucine [24]. This suggests
the possibility that the immediate cellular response
towards amino acid withdrawal is autophagy either
through sequestration of protein substrates to lysosomes
or through modification of mRNA levels for lysosomal
proteases, but is followed by longer term activation of
ubiquitin-proteasome pathway. The activation of lyso-
somal pathway in response to total amino acid depriva-
tion as reported by the previous study is more likely due
to cell stress [13].
In vitro studies using L6 or human muscle cells have con-
firmed the inhibitory effects of insulin on muscle protein
degradation [25,26]. Furthermore the mechanism of insu-
lin action appears to be mediated by a decrease in the
activity of the ubiquitin-proteasome pathway [25]. Both
in vitro [9] and in vivo [10] studies have demonstrated that
insulin down regulates the expression of 14-kDa E2 ubiq-
uitin conjugating enzyme and ubiquitin, respectively. The
present study demonstrates that the inhibitory action of
Leucine increases the inhibitory effect of insulin on protein  degradation in C2C12 myotubes Figure 6
Leucine increases the inhibitory effect of insulin on 
protein degradation in C2C12 myotubes. Fully differen-
tiated myotubes were pre labelled with L[ring -3, 5-3H]-tyro-
sine for 48 hours. Myotubes were rinsed twice with 1 × HBS 
and chased in 0.2 × PC AA medium for 2 hours followed by 
incubation with 30 (filled bars), 150 (open bars) and 750 
(hatched bars) μM leucine in 0.2 × PC AA medium. Values 
are means ± SEM for two experiments performed in quadru-
plets. * Represents significant differences among leucine lev-
els whereas ψ indicates differences relative to control 
groups.BMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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insulin on expression of components of the proteasome
pathway is decreased when either amino acids or leucine
concentrations in the media are decreased to 0.2 × physi-
ological concentrations. In vivo, the starvation-induced
increase in muscle proteasome-dependent proteolysis is
only slowly reversed over 12 h of refeeding rats and acute
infusion of amino acids over 3 h fail to alter the expres-
sion of components of the proteasome pathway [23]. A 6-
hour hyperinsulinaemic, hyper-aminoacidaemic infusion
study significantly reduced the mRNA expression for
ubiquitin in fast twitch and mixed skeletal muscle [10].
These data combined with our own suggest that under
normal fed conditions insulin and amino acids act
together to suppress the ubiquitin-proteasome pathway
and that the fasting-induced increase in muscle protein
degradation is due to lowered insulin and amino acid cir-
culating concentrations resulting in enhanced expression
of members of the proteasome pathway.
Numerous studies have demonstrated that insulin and
amino acids regulate muscle protein synthesis and hepatic
autophagy through the mTOR [18-29]. Inhibition of the
mTOR pathway by rapamycin abolishes the effect of leu-
cine media starvation on autophagic proteolysis in C2C12
myotubes [13]. Here, we demonstrate that rapamycin
blocked the inhibitory effects of increasing amino acid
concentration from 0.2 to 1.0 × PC AA, on protein degra-
dation, but did not block the inhibitory effect of either
leucine or insulin. In agreement with the present results,
previous studies have demonstrated that leucine sup-
presses proteolysis in skeletal muscle and hepatocytes by
an mTOR independent mechanism[15,30,31]. Since our
observations demonstrated that amino acid mixtures sup-
pressed proteolysis in an mTOR dependent manner, this
suggests that the mTOR pathway is influenced by amino
acids other than the branched chain amino acid group. It
has been proposed that glutamate and glutamine have
suppressive effects on proteolysis in muscle [32] and stud-
ies in other cell types have demonstrated that these amino
acids influence the mTOR signalling pathway [33,34].
Phoshorylation targets for mTOR have been proposed to
be S6 kinase and 4E-BP1 as well as the phosphorylation
Effect of insulin and 30 (filled bars), 150 (open bars) and 750 (hatched bars) μM leucine on ubiquitin-proteasome pathway Figure 7
Effect of insulin and 30 (filled bars), 150 (open bars) and 750 (hatched bars) μM leucine on ubiquitin-proteas-
ome pathway. Experimental procedure is the same as described under Figure 6. Autoradiographic signals normalised for 
GAPDH were analysed as described under fig 5. * Symbolises significant difference between 30 and 750 μM leucine.BMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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dependent control of the degradation of many F-box pro-
teins. Phosphorylation of S6 kinase by insulin greatly
depends on amino acid availability [35] and leucine alone
has been reported to induce S6 activation [36,37]. We
were also able to demonstrate that rapamycin inhibited
amino acid or insulin-dependent p70 S6 kinase phospho-
rylation. These changes were paralleled by a consistent
trend for an increase in mRNA for 14-kDa E2 enzyme. The
expression of several muscle-specific E3 ubiquitin ligases
is consistently increased in conditions causing muscle
wasting and mouse knock out studies have demonstrated
that these are required for muscle atrophy [38]. Insulin
and insulin-like growth factor-1 acting through the PI3-k/
AKT pathway, suppress the expression of E3 ligases,
MuRF1 and MAFbx/atrogin-1 [39]. Taken together, the
present study argues that amino acids act through mTOR
to regulate myofibrillar proteasome-dependent proteoly-
sis but further studies are necessary to establish the down
stream effector pathways responsible for changes in the
expression of components of the proteasome complex.
Conclusion
In conclusion we provide evidence that depletion of a
mixture of amino acid in the media of C2C12 myotubes
increases proteasome-dependent-proteolysis and the
expression of the components of the ubiquitin-proteas-
ome pathway. Theses effects of amino acids were additive
with those of insulin, not simply related to changes in leu-
cine, and appear to be mediated by the mTOR pathway.
Further studies are required to establish the exact signal-
ling pathways by which amino acids alter the activity of
the proteasome pathway to provide pharmacological tar-
gets to combat muscle wasting which is associated with
various pathological states, such as prolonged starvation,
sepsis, cancer cachexia and diabetes.
Methods
Cell culture
Medium, sera, vitamins solution, and antibiotic/antimy-
cotic were bought from GIBCO BRL, Paisley, UK. Proteas-
ome inhibitor MG132 was from Merck Biosciences,
Nottingham, UK. Rapamycin was from SIGMA Chemicals
Company, Poole, Dorset, UK. The C2C12 mouse cell line
was purchased from the ATCC and was used between pas-
sage numbers 14 and 19. Cells were grown in Dulbecco's
modified Eagle's medium (DMEM) supplemented with
10% (v/v) foetal bovine serum (FBS), 44 mM NaHCO3,
25 mM D-glucose and 1 mM sodium pyruvate in a humid-
ified environment of 5% CO2 and 95% O2 at 37°C. Cells
were seeded in 12 well plates (for tyrosine release assay)
or 6 well plates (for RNA analyses) or in 90 mm dishes
(for phosphorylation studies). The cells were grown in the
presence of 10% FBS for 2–3 days until confluent, at
which time the medium was replaced with fusion
medium i.e., DMEM containing 10% horse serum (HS) to
induce differentiation. The defined medium used in the
studies was made up of vitamin solution, constituents of
the RPMI – 1640 Select – Amine™ kit (GIBCO BRL), a mix-
ture of rat physiological concentration amino acids (PC
AA) (Table 1), 25 mM D-glucose, antibiotic/antimycotic,
24 mM NaHCO3, 1 mM Sodium pyruvate, 2 mM tyrosine
(specially added to avoid reincorporation of tyrosine in
proteolysis measurements) and phenol red. Either 1.0 ×
PC AA or 0.2 × PC AA media were employed in the stud-
ies. The only difference was in the concentration of amino
acids. pH of the medium was adjusted to 7.4 with 1 M
HCl before use. Where stated MG132 was added at 50 uM
and did not have any effect on cell viability.
Creatine phosphokinase (CPK) and total protein 
measurement
Cells (passage 16) were seeded in 6-well plates and incu-
bated in 5% CO2 and 95% O2 at 37°C until confluent. At
this stage (Day 0), media was removed from 3 wells, cells
were rinsed thrice with ice cold 1 × phosphate buffer
saline (PBS) and kept at -80°C in 1 × Hanks balanced salt
Effect of rapamycin on p 70 S6 kinase phosphorylation status  in C2C12 myotubes incubated with insulin and 1.0 × PC AA Figure 8
Effect of rapamycin on p 70 S6 kinase phosphoryla-
tion status in C2C12 myotubes incubated with insulin 
and 1.0 × PC AA. Myotubes were serum starved overnight 
and next morning treated with rapamycin (2.2 × 10-8 M) in 
1.0 × PC AA for 20 min. Half of the rapamycin treated or 
non treated cells were then stimulated with insulin (10-8 M) 
for another 20 min. A) immunodetection on western blot, B) 
respective densitometric analyses. Values are mean ± SEM 
from one experiment performed in duplicates.BMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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solution (HBSS; SIGMA) until analyses. Growth medium,
in the remaining plates, was replaced with fusion medium
and samples in triplicates were then collected every 24
hours for 5 days. CPK activity and protein content in the
samples were analysed using commercial kits from
SIGMA and BioRad, respectively, according to manufac-
turer's instructions.
Tyrosine release assay for measuring proteolysis
Protein degradation was determined by monitoring the
release of TCA soluble radioactive tyrosine into the culture
medium [40]. Fully differentiated myotubes from day 5
were radiolabelled with 1 μCi L[ring -3, 5-3H]-tyrosine/ml
fusion medium for 48 hours in an atmosphere of 5% CO2
and 95% O2 at 37°C to label cellular proteins. Monolay-
ers were rinsed with 1 × HBSS and incubated with serum
free defined medium for two hours at 37°C to allow the
degradation of short live proteins. Myotubes were then
rinsed twice with 1 × HBSS and chased once again for 8
hours in defined medium containing 0.05% (w/v) bovine
serum albumin (BSA) with or without insulin or other
agents. At the end of incubation period media was
removed into tubes containing 1 mg BSA and precipitated
overnight (for convenience) with an equal volume of 20%
(w/v) TCA at 4°C. Tubes were centrifuged at 3000 g at 4°C
for 5 min and supernatant containing soluble proteins (A)
was separated. TCA insoluble proteins (B) in the pellets
and myotubes (C) in the plates were solubilised in 0.5
and 1.0 ml of tissue solubiliser (0.5 M NaOH and 0.1%
Triton X-100), respectively. One hundred microlitres of
each fraction of protein (A, B and C) was counted using
Packard Scintillation counter. Percent protein degradation
was calculated by dividing radioactivity in TCA soluble
protein (A) by sum of radioactivity in TCA soluble (A),
TCA insoluble (B) and in myotubes (C).
Northern hybridisation for components of ubiquitin-
proteasome pathway
Differentiated myotubes were used from day 5. Experi-
mental conditions used for tyrosine release assay were
reproduced except that cold tyrosine was used instead of
L[ring -3, 5-3H]-tyrosine. At the end of 8 h incubation
period myotubes were rinsed with ice cold 1 × HBS and
total RNA was extracted using Tri Reagent (SIGMA)
according to the manufacturer's guidelines. The quantity
and purity of RNA were assessed by observing absorption
at 260 and 280 nm.
Ten micrograms of RNA was run on 1% agarose formalde-
hyde denaturing gel, transferred to Genescreen™ mem-
brane (NEN Life science products, Inc. Boston,
Massachusetts, USA) and covalently fixed to the mem-
brane by UV irradiation. Strippable probes, either of
cDNA for 14-kDa E2 ubiquitin conjugating protein, C2
and C8 20 S proteasome subunits and glyceraldehyde 3
Effect of rapamycin on total protein degradation Figure 9
Effect of rapamycin on total protein degradation. 
Myotubes were incubated with 0.2 × PC AA (filled bars) or 
1.0 × PC AA (open bars) media (A), or with 30 (filled bars) 
and 750 (hatched bars) μM leucine in 0.2 × PC AA medium 
(B). After labelling C2C12 myotubes for 48 hours, cells were 
incubated with 0.2 × PC AA or 1.0 × PC AA for two hours. 
Rapamycin (RAP) 2.2 × 10-8 M was then added to half of the 
wells containing 0.2 × PC AA or 1.0 × PC AA and dishes 
transferred back to incubator. Twenty minutes later insulin 
10-8 M was added in to half of the rapamycin treated and half 
of the untreated cells and incubated at 37°C for another 8 
hours. Since rapamycin has half-life of about 3–4 hours media 
was supplemented with rapamycin after the first four hours 
of incubation. Data represent mean ± SEM from one or two 
experiments performed in triplicates. * Indicates differences 
between two amino acids concentrations, ψ represents 
rapamycin treated versus non-rapamycin treated (control) 
group and # symbolises difference between insulin and 
rapamycin treated versus insulin treated groups.BMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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phosphate dehydrogenase (GAPDH, a house keeping
gene) were synthesized with [α-32P] dATP to a specific
activity of 109 cpm/μg cDNA using Ambion Strip EZ DNA
kit (AMS Biotechnology ltd, Witney Oxon, UK). Unincor-
porated radioactivity was removed by passing the synthe-
sized probe through chromaspin – 30 column (Clonetech
laboratories ltd, Hampshire, UK). Membranes were pre-
hybridised with Quickhyb hybridisation solution (Strata-
gene cloning system, California, USA) for 20 min at 65°C.
Purified probe containing salmon sperm DNA (Ambion)
was denatured at 90°C for 10 min and transferred to the
hybridisation solution. Probe was then hybridised to the
RNA on the blot for two hours at 65°C. To remove non-
specific binding the blot was washed twice with 2 × SSC/
0.1% SDS at 60°C for 15 min each and then once with 1×
SSC/0.1% SDS at 65°C for 15 min. Autoradiographic sig-
nals were quantified by laser densitometry and expressed
relative to the corresponding GAPDH mRNA value to nor-
malise for equal loading and transfer of RNA. GAPDH was
used because previous studies with nutrients and hor-
mones have documented that mRNA level for it remains
constant [10]. Membranes were stripped using Strip EZ kit
and rehybridised with other components of the ubiquitin-
proteasome pathway as described above.
Western blotting and immuno detection for p70 S6 kinase 
phosphorylation
Myotubes from day 6 were incubated over night in 1 × PC
AA medium containing 0.05% (w/v) BSA in a humidified
atmosphere of 5% CO2 and 95% O2 at 37°C. Next morn-
ing medium was replaced with 5 ml of fresh 1 × PC AA
medium containing 0.05% (w/v) BSA and dishes were
transferred back to the incubator at 37°C. After 60 min
half of the dishes were treated with 2.2 × 10-8 M rapamy-
cin for 20 min at 37°C in 5% CO2 and 95% O2. Following
this half of the rapamycin treated and non-treated dishes
were stimulated with 10-8 M insulin for another 20 min.
Medium was aspirated and monolayers were rinsed with
ice cold 1 × PBS. Cells were lysed by adding pre heated
(95°C) buffer composed of 62.5 mM Tris-HCl (pH 6.8),
2% (w/v) SDS, 1.55% (w/v) dithiothretol (DTT), 10% (v/
v) glycerol and 0.01% (w/v) bromophenol blue, on them.
Cells were scraped of and immediately transferred in to
1.5 ml micro centrifuge tubes and passed through a 25
guage needle 5 times to break cellular nucleoprotein com-
plexes. Cell extracts thus obtained were heated at 95°C for
5 min and stored at -80°C until further analyses.
Equal concentration of protein from cell extracts was
resolved on 10% SDS polyacrylamide gel. Gel was run at
a constant voltage of 80 for 3 hours and then transferred
overnight on to polyvinylidene diflouride (PVDF) mem-
brane (NEN) at a constant current of 300 mA at 4°C. Pro-
tein was heat fixed to the membrane at 65°C for 30 min
to expose antibody binding epitopes on the antigen. Prior
to immunodetection, heat fixed membrane was briefly
soaked in 100% methanol, followed by a 5 min wash in 1
× TBS (20 mM Tris-HCl, 137 mM NaCl, pH 7.6) at room
temperature. Membrane was blocked in 1 × TBST buffer (1
× TBS containing 0.1% (v/v) Tween-20 and 5% (w/v) non
fat dry milk) for 1.5 hour at room temperature. Mem-
brane was incubated overnight with primary antibody,
phospho-p70 S6 kinase (Thr 389) (New England Biolabs
(UK) ltd., Hertfordshire, England), dilution 1: 1000 in 1 ×
TBST containing 5% (w/v) BSA at 4°C. The next morning,
membrane was washed four times with 1 × TBST for 5 min
each at room temperature and incubated with HRP-linked
anti-rabbit secondary antibody, dilution 1: 2000 in 1 ×
TBST containing 5% (w/v) BSA at 25°C for an hour.
Finally membrane was washed again as before and HRP-
protein substrate complex was detected using lumiglo
detection system (New England Biolabs) according to the
Effect of rapamycin on the expression of 14-kDa E2 ubiquitin  conjugating enzyme in C2C12 myotubes incubated with or  without insulin in 1× PC AA Figure 10
Effect of rapamycin on the expression of 14-kDa E2 
ubiquitin conjugating enzyme in C2C12 myotubes 
incubated with or without insulin in 1× PC AA. The 
same experimental procedure was employed as described 
under Figure 9A. Values represent mean ± SEM from a single 
experiment performed in triplicates. * Symbolises significant 
difference relative to control group.BMC Molecular Biology 2007, 8:23 http://www.biomedcentral.com/1471-2199/8/23
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manufacturer's instructions. Membrane was exposed to
Amersham Hyperfilm and the intensity of bands observed
was quantified by laser densitometry. The membrane was
stripped at 55°C for 20 min in a buffer composed of 62
mM Tris-HCl, pH 8.0, 2% (w/v) SDS, 0.7% (v/v) β mer-
captoethanol. The blot was then reprobed for anti-p 70 S6
kinase that can recognise both phospho and dephospho
antigenic sites.
Statistical analyses
Values are presented as means ± SEM. Differences of
means were determined by Analysis of variance in a Gen-
eral Linear Model, running Minitab version 13.1. Post hoc
comparisons were performed by Tukey's pair wise com-
parison for multiple treatments. p < 0.05 was accepted as
a significant difference between treatments.
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